Q4 2021 Holdings
Filed 2022-02-11 | 9 holdings | $63.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $49.4M | 3,399,034 | 78.0% |
| Cue Health Inc.(HLTHQ) | COM | 229790100 | $13.5M | 1,006,089 | 21.3% |
| Kinnate Biopharma Inc. | COM | 49705R105 | $171.4K | 9,671,643 | 0.3% |
| Lyell Immunopharma, Inc. | COM | 55083R104 | $102.8K | 13,282,181 | 0.2% |
| Pharvaris N.V.(PHVS) | COM | N69605108 | $46.9K | 3,261,926 | 0.1% |
| Quantum-Si Incorporated(QSI) | COM CL A | 74765K105 | $35.1K | 4,463,619 | 0.1% |
| Nurix Therapeutics, Inc.(NRIX) | COM | 67080M103 | $34.9K | 1,205,798 | 0.1% |
| Kura Oncology, Inc.(KURA) | COM | 50127T109 | $25.9K | 1,849,947 | 0.0% |
| Cymabay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $6.0K | 1,787,094 | 0.0% |